These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9146544)

  • 1. Fixed drug eruptions with feprazone are linked to HLA-B22.
    Pellicano R; Lomuto M; Ciavarella G; Di Giorgio G; Gasparini P
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):782-4. PubMed ID: 9146544
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22.
    Pellicano R; Ciavarella G; Lomuto M; Di Giorgio G
    J Am Acad Dermatol; 1994 Jan; 30(1):52-4. PubMed ID: 8277031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial occurrence of fixed drug eruptions.
    Pellicano R; Silvestris A; Iannantuono M; Ciavarella G; Lomuto M
    Acta Derm Venereol; 1992 Aug; 72(4):292-3. PubMed ID: 1357892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some studies of feprazone.
    Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V
    Rheumatol Rehabil; 1976 May; 15(2):81-6. PubMed ID: 132695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact dermatitis from feprazone.
    Cusano F; Luciano S; Iannazzone S; Adamo F
    Contact Dermatitis; 1993 Feb; 28(2):109. PubMed ID: 8458203
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal failure complicating feprazone treatment.
    Robertson C; Innes S; Paton J
    Hum Toxicol; 1981; 1(1):71-2. PubMed ID: 6217146
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia.
    Dermatology; 1993; 186(3):164-9. PubMed ID: 8453140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug eruptions induced by allopurinol associated with HLA-B*5801.
    Zeng M; Zhang M; Liu F; Yan W; Kong Q; Sang H
    Indian J Dermatol Venereol Leprol; 2015; 81(1):43-5. PubMed ID: 25566896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized dermographism at the site of a fixed drug eruption.
    Pellicano R; Camassa F; Lomuto M
    Br J Dermatol; 1995 Jan; 132(1):156-8. PubMed ID: 7756134
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexisting linear and disseminated drug eruption: a clinical clue to the understanding of the genetic basis of drug eruptions.
    Happle R; Effendy I
    Eur J Dermatol; 2001; 11(2):89. PubMed ID: 11275799
    [No Abstract]   [Full Text] [Related]  

  • 11. Miscellaneous rheumatological conditions treated in monitored-release studies with feprazone.
    Harris PG
    J Int Med Res; 1981; 9(4):248-52. PubMed ID: 6973494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between HLA-B and cutaneous reactions to sulphonamides in human immunodeficiency virus-infected patients.
    Vitezica ZG; Wolkenstein P; Lonjou C; Eliaszewicz M; Sicard X; Roujeau JC; Hovnanian A
    Br J Dermatol; 2008 Aug; 159(2):501-3. PubMed ID: 18547316
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA and antibiotic allergic skin eruption.
    Chan SH; Tan T; Wee GB; Lim AY
    Ann Acad Med Singap; 1988 Oct; 17(4):518-9. PubMed ID: 2975936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal arthritis: Is HLAB genotyping the future of gout pharmacogenomics?
    Singh JA
    Nat Rev Rheumatol; 2013 Apr; 9(4):200-2. PubMed ID: 23399693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed drug eruption due to nabumetone in a patient with previous fixed drug eruptions due to naproxen.
    Pérez-Calderón R; Gonzalo-Garijo MA; Pérez-Rangel I; Sánchez-Vega S; Zambonino MA
    J Investig Allergol Clin Immunol; 2011; 21(2):153-4. PubMed ID: 21462807
    [No Abstract]   [Full Text] [Related]  

  • 16. Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype.
    Ozkaya-Bayazit E; Akar U
    J Am Acad Dermatol; 2001 Nov; 45(5):712-7. PubMed ID: 11606921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
    Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273
    [No Abstract]   [Full Text] [Related]  

  • 18. Fixed drug eruptions: a case report and review of the literature.
    Gendernalik SB; Galeckas KJ
    Cutis; 2009 Oct; 84(4):215-9. PubMed ID: 19911677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative.
    Bonta PI; Vermeulen JN; Speelman P; Prins JM
    AIDS; 2008 Jul; 22(12):1522-3. PubMed ID: 18614879
    [No Abstract]   [Full Text] [Related]  

  • 20. Occupationally induced fixed drug eruption caused by a non-steroidal anti-inflammatory agent.
    Lamchahab F; Baeck M
    Contact Dermatitis; 2012 Sep; 67(3):176-7. PubMed ID: 22897784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.